01 1Synbias Pharma AG
01 1DOXORUBICIN HYDROCHLORIDE
01 1Switzerland
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-02-14
Pay. Date : 2014-01-28
DMF Number : 16178
Submission : 2002-10-09
Status : Active
Type : II
20
Synbias Pharma Ag, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DOXORUBICIN HYDROCHLORIDE, with a corresponding US DMF Number 16178.
Remarkably, this DMF maintains an Active status since its submission on October 09, 2002, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 14, 2014, and payment made on January 28, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
